3 Analyst-Backed Pharmaceutical Stocks With Great Projections

For investors specifically interested in keeping tabs on the pharmaceutical industry, checking in with the latest news from analysts can be a helpful tool in finding new opportunities. Today, we have a quick list of pharmaceutical stocks that have been recently noted to be a 'Buy' or 'Strong Buy' by analysts. Additionally, all of these companies met the high-growth projection requirements. Take a look at the list below to begin your research process.EPS growth (earnings per share growth) illustrates the growth of earnings per share over time. The 1-Year Expected EPS Growth Rate is an annual growth estimate, where the growth projections are made by analysts, the company or other credible sources.We first looked for pharmaceutical stocks. From there, we looked for companies that analysts rate as "Buy" or "Strong Buy" (mean recommendation <3). We then looked for companies that have high future earnings per share growth forecasts
... Read the rest at SeekingAlpha.com